Mesa Laboratories
MLAB
101 hedge funds and large institutions have $394M invested in Mesa Laboratories in 2017 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 35 increasing their positions, 23 reducing their positions, and 5 closing their positions.
220% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 5
52% more repeat investments, than reductions
Existing positions increased: 35 | Existing positions reduced: 23
12% more funds holding
Funds holding: 90 → 101 (+11)
9% more capital invested
Capital invested by funds: $362M → $394M (+$32M)
2.44% more ownership
Funds ownership: 67.47% → 69.91% (+2.4%)
0% more funds holding in top 10
Funds holding in top 10: 1 → 1 (0)
Top Buyers
Top Sellers
MLAB Hedge Fund Activity: Q3 2017 in Review
101 of the 4,011 institutional investors tracked by Wall St. Rank reported a position in Mesa Laboratories (MLAB) for Q3 2017, worth a combined $394M — up 8.8% from $362M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new MLAB positions and 5 closed out — a net gain of 11 holders — while 35 added to existing stakes and 23 trimmed.
The largest buyer was Lord, Abbett & Co, opening a new position worth an estimated $4.15M. The largest seller was Nine Ten Capital Management, cutting an estimated $4M.
- 101 institutional investors held Mesa Laboratories (MLAB) as of Q3 2017, up from 90 in Q2 2017.
- Funds reported $394M of Mesa Laboratories stock for Q3 2017, up 8.8% quarter-over-quarter.
- 16 funds opened new Mesa Laboratories positions in Q3 2017 and 5 closed out, a net change of +11 holders.
- The largest Mesa Laboratories buyer in Q3 2017 was Lord, Abbett & Co, an estimated $4.15M added.
- The largest Mesa Laboratories seller in Q3 2017 was Nine Ten Capital Management, an estimated $4M sold.
Based on aggregated 13F filings for Q3 2017.